武功密笈 小黃藏書 |
|
~ Urinary Incontinence ~
ª Definition:1). Incontinence: involuntary urine loss that is a social or hygienic problem 2). Stress incontinence: incontinence occurring under conditions of increased intra-abdominal
3). Urge incontinence: incontinence accompanied by a strong desire to void 4). Mixed incontinence: stress and urge incontinence occurring together 5). Unconscious incontinence: incontinence occurring without urgency and without conscious
6). Frequency: the number of voids per day, from waking in the morning until falling asleep at
7). Nocturia: the number of times the patient is awakened from sleep to void at night 8). Nocturnal enuresis: urinary incontinence during sleep
ª Differential Diagnosis:
ª Investigation:1). Basic evaluations: ? History: α-agonist, α-blocker, Ca++-channel blocker, etc. – Drugs with anticholinergic properties: antihistamines, antidepressant, antipsycotics, opiates, antispasmodics, and drugs for Parkinson’s disease. ‚ Physical Examination:
ƒ U/A: to rule out infection, which can be associated with incontinence „ Postvoid Residual Urine: - Incomplete bladder emptying is a frequent cause of incontinence. … Frequency/Volume Bladder Chart:
¤ Daily urine output: 1500-2500 ml¤ Total number of daily voids: 7 or 8¤ Average voided volume: approximately 250 ml¤ Functional bladder capacity: 400-600 ml† Urodynamic Studies:
a). Uroflowmetry b). Cystometry : to measure pressure/volume relationship of bladderw Two phases: filling cystometry and voiding cystometry w Simple cystometry: measuring bladder pressure only during filling w Subtracted cystometry: ° An attempt to measure the pressure exerted in the bladder by detrusor ves), intra-abdominal pressure (Pabd), to give true detrusor pressure (P det)det = Pves - Pabd ° Measurement and its normal value: ? Residual urine: < 50 mlFirst desire to void: occurring between 150-250 ml infused ƒ Strong desire to void: not occurring until > 250 ml„ Cystometric capacity : 400-600 ml… Bladder compliance: between 20-100 ml/cm H2O measured 60seconds after reaching cystometric capacity † No uninhibited detrusor contractions during filling, despite provocation ‡ No stress or urge incontinence demonstrated, despite provocation ˆ Voiding occurs because of a voluntarily initiated and sustained detrusor contraction ‰ Flow rate during voiding: > 15 ml/sec, with Pdet < 50 cm H2Oc). Pressure-flow voiding studies d). Urethral pressure profile :w Generated by slowly pulling a pressure-sensitive catheter through the urethra from the bladder, which is usually filled with a consistent volume of fluid w P close = Pure - Pves( Pclose: urethral closure pressure, Pure: urethral pressure, Pves: bladder pressure)e). Leak-point pressure :w The intravesical (or intra-abdominal) pressure measured at the moment that stress incontinence occurs 2). Others: - Urine Cytology, IVP, Cystoscopy with Biopsy, etc.
ª Extraurethral Causes of Incontinence: (urine loss through abnormal opening)1). Bladder exstrophy 2). Ectopic ureter 3). Urinary Fistula: · Worldwide, the most common cause of fistula: obstructed labor· In the industrialized world, the most common cause of fistula: surgery, malignancy, and radiotherapy · Repair of fistula: j Timing: after a waiting period of 3 months to allow the resolution of inflammation
ª Stress Urinary Incontinence:1). Definition: - Urine leaks when intra-abdominal pressure rises and becomes a social or hygienic problem. 2). Conditions resulting stress incontinence:
3). GSI: è Diagnosis: A urodynamic diagnosis - Demonstrable urinary leakage when intravesical pressure exceeds the maximum urethral closure pressure in the absence of a detrusor contraction è Biobehavioral Model: ~ interaction of three variables
è Two Types: À GSI caused by anatomic hypermobility of urethra - more prevalent, accounting for 80-90% of stress urinary incontinence
S Effective urethral closure is maintained by the interaction of extrinsic urethral support and intrinsicurethral integrity 4). Treatment: ¬ Non-surgical management:¥ Muscle strengthening: eg. Kegel exercise¥ Drug therapy:a). a -adrenergic drugs (possible complication: hypertension)
¥ Electrical stimulation Surgical management: ¥ Anterior colporrhaphy:° Indications: cystocele without significant stress incontinence ° Mechanism: to prevent excessive displacement of endopelvic fascia beneath the
° Methods: a). simple plication of the bladder neck b). elevation of the bladder neck by placating the fascia under the urethra c). elevation and fixation of the bladder neck by passing sutures lateral to the
° Advantage: a). Avoid abdominal incision. b). Allow the operation to be performed in conjunction with other vaginal
° Disadvantage: long-term success rate only 35-65% ¥ Operations to correct stress incontinence resulting from anatomic hypermobility(retropubic bladder neck suspension, needle suspension procedures)
° Indication: stress incontinence with hypermobility of urethra/bladder neck° Mechanism: to correct anatomic hypermobility of urethra/bladder neck° Methods:a). Marshall-Marchetti-Krantz operation: periurethral fascia « back of pubic symphysis b). Burch colposuspension: fascia at the level of bladder neck « iliopectineal (Cooper’s) ligament c). Turner-Warwick vagino-obturator shelf procedure: endopelvic fascia and/or vagina « fasia of obturator internus muscle ° Advantage: long-term success rate 80-90%° Complications:a). urethral kinking or obstruction g voiding difficulty b). osteitis pubis, when suture is put directly into the pubic symphysis c). enterocele, uterine prolapse, vaginal vault eversion, when opening the rectouterine pouch of Doaglas by pulling up on the ant. vagina and then elevating the post. Vagina „ Culdoplasty is recommended at the time of bladder neck suspension
B . Transvaginal urethropexy (Needle suspension procedures):° Indication: stress incontinence resulting primarily from anatomic hypermobilityof bladder neck and urethra ° Mechanism: suspension of the urethra and bladder neck through a techniquethat involves passage of sutures between the vagina and ant. abdominal wall ° Advantage: simple, short operation duration° Disadvantage:a). 5-year success rate ? 50% b). perforation of bladder of urethra c). infection d). granulation formation around sutures e). prolapse development f). chronic pulling pelvic pain created by suture material g). nerve entrapment syndrome ¥ Operations to correct stress incontinence resulting from intrinsic sphincteric weaknessor dysfunction (sling operations, periurethral injections)
° Indication: complicated stress incontinence, usually from intrinsic weaknessa). demonstrable stress incontinence with normal urethral support b). stress incontinence with a low leak-point pressure c). stress incontinence with very heavy occupational lifting d). stress incontinence with severe chronic obstructive lung disease e). stress incontinence with posthysterectomy vaginal vault eversion ° Mechanism:a). creating some degree of outlet obstruction (major) (compressing the urethral lumen at the level of the bladder neck to compensate for a faulty urethral closure mechanism) b). providing urethral support ° Complication: obstructed voidingB. Periurethral injection: ° Indication: intrinsic urethral failure° Mechanism: injection of material around the periurethral tissue to facilitate theircoaptation under conditions of increased intra-abdominal pressure ° Material utilized:Polytef, Contigen (allergic reaction < 3%), Teflon, etc. ° Long-term success rate: poorly studied¥ Salvage operations (intentionally obstructive sling operations, implantation of anartificial urinary sphincter, urinary diversion) ~ a last ditch effort for cure ° Indication: scarred, fibrotic, nonfunctional urethra
ª Urinary Incontinence Caused by Detrusor Overactivity:* The most common form of incontinence in older women * The second most common form of urinary incontinence overall * Detrusor overactivity: j Detrusor hyperreflexia: when this occurs as the result of a known neuropathologic process relevant to bladder disorder (eg. stroke, Parkinson’s disease, multiple sclerosis)
* Diagnosis: ¬ Symptoms:
* Treatment: (initially ¬ + ; long-term management based on ) ¬ Drug therapy: mainly anticholinergic
- Anti-cholinergic adverse effects: dry month, increased heartbeat, constipation, blurred vision Behavior therapy: timed voiding, gradual increases in the interval between voids, until the
- poor response in patients with detrusor hyperreflexia
ª Mixed Incontinence:* Treatment alternatives: j to determine and treat the most bothersome component
ª Functional or Transient Incontinence:ò “DIAPPERS”: (reversible causes of incontinence) DeliriumInfection Atrophic urethritis and vaginitis Pharmacologic causes Psychological causes Excessive urine production (eg. diabetes, hypercalcemia, or excessive fluid intake) Restricted mobility Stool impaction ò Medical reversible condition ò Appropriate medical intervention can cure or improve the continence problem without resorting to
Filename: Urinary Incontinence |